Advance your academic career, collaborate globally, and expand your network— join now !

Thomas Efferth

Prof. Thomas Efferth

Department of Pharmaceutical Biology, Institute of Pharmacy and Biomedical Scien...

Share Link

Share

Information

Thomas Efferth graduated from the Technical University Darmstadt and received his Ph.D. from the German Cancer Research Center, Heidelberg, Germany. He completed his Habilitation at the Technical University Aachen, Germany. In 2005, he served as a research group leader at the German Cancer Research Center, followed by his appointment as an associate professor at the University of Heidelbergin in 2007. In 2009, he became a full professor and the Chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Germany. Additionally, he held several honorary positions, including positions at the Northeast Forestry University, Harbin, China (2006), the Zhejiang Medical University, Hangzhou, China (2015), visiting professor at the Zhejiang University for Science and Technology, Hangzhou, China (2015), honorary adjunct professor at the Chinese University of Hong Kong (2018), and honorary professor at the Hong Kong Baptist University (2019). He is now a professor of Molecular Pharmacology and Toxicology of anti-cancer drugs at the Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. He has received numerous awards, including the SFE Outstanding International Ethnopharmacologist Award (2021), the High Impact Paper Award of the journal “Engineering” (edited by the Chinese Academy of Engineering) for the fifth-most cited paper in 2019 (top 3.5%) (2021).

Research Keywords & Expertise

Cancer Biology
Pharmacology
Traditional Chinese Me...
biomolecules
natural product

Short Biography

Thomas Efferth graduated from the Technical University Darmstadt and received his Ph.D. from the German Cancer Research Center, Heidelberg, Germany. He completed his Habilitation at the Technical University Aachen, Germany. In 2005, he served as a research group leader at the German Cancer Research Center, followed by his appointment as an associate professor at the University of Heidelbergin in 2007. In 2009, he became a full professor and the Chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Germany. Additionally, he held several honorary positions, including positions at the Northeast Forestry University, Harbin, China (2006), the Zhejiang Medical University, Hangzhou, China (2015), visiting professor at the Zhejiang University for Science and Technology, Hangzhou, China (2015), honorary adjunct professor at the Chinese University of Hong Kong (2018), and honorary professor at the Hong Kong Baptist University (2019). He is now a professor of Molecular Pharmacology and Toxicology of anti-cancer drugs at the Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. He has received numerous awards, including the SFE Outstanding International Ethnopharmacologist Award (2021), the High Impact Paper Award of the journal “Engineering” (edited by the Chinese Academy of Engineering) for the fifth-most cited paper in 2019 (top 3.5%) (2021).